Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Mallinckrodt
Mallinckrodt
Mallinckrodt to sell Therakos unit to CVC Capital for $925 mln
Reuters
Mon, 08/5/24 - 11:07 pm
Mallinckrodt
M&A
Therakos
Mallinckrodt emerges from bankruptcy
Beckers Hospital Review
Wed, 11/15/23 - 11:44 pm
Mallinckrodt
bankruptcy
Mallinckrodt looking at a second bankruptcy filing
Pharmaphorum
Thu, 08/24/23 - 10:20 am
Mallinckrodt
bankruptcy
opioids
opioid crisis
Drugmaker Mallinckrodt considers second bankruptcy filing, other options
Yahoo/Reuters
Wed, 08/16/23 - 11:27 pm
Mallinckrodt
bankruptcy
opioids
opioid crisis
Despite recent sales growth, Mallinckrodt keeps financial options—including bankruptcy—on the table
Fierce Pharma
Wed, 08/9/23 - 10:04 am
Mallinckrodt
bankruptcy
opioids
legal
Mallinckrodt faces investor lawsuit for allegedly making false statements about its financial health
Fierce Pharma
Sun, 07/16/23 - 02:57 pm
Mallinckrodt
legal
investors
opioids
FDA Review: Abiomed, Mallinckrodt, Aro and More
BioSpace
Sun, 09/18/22 - 10:42 pm
FDA
devices
Medtech
Abiomed
cardiogenic shock
clinical trials
Impella
Mallinckrodt
Kymera Therapeutics
Aro Biotherapeutics
Mallinckrodt secures FDA approval — but not without warning
Endpoints
Thu, 09/15/22 - 11:18 pm
Mallinckrodt
FDA
terlipressin
Terlivaz
liver disease
hepatorenal syndrome
Mallinckrodt tries again with kidney drug terlipressin
Pharmaforum
Wed, 06/15/22 - 10:41 am
Mallinckrodt
terlipressin
hepatorenal syndrome
Mallinckrodt Agrees to Pay $260 Million to Settle Lawsuits Alleging Underpayments of Medicaid Drug Rebates and Payment of Illegal Kickbacks
DOJ
Tue, 03/8/22 - 10:15 am
Mallinckrodt
False Claims Act
Medicaid
kickbacks
legal
FDA knocks back Mallinckrodt’s kidney drug terlipressin
Pharmaforum
Wed, 02/23/22 - 10:26 am
Mallinckrodt
hepatorenal syndrome
kidney disease
terlipressin
Mallinckrodt moves closer to resolving its opioid liability hangover
Pharmaforum
Mon, 09/6/21 - 09:09 pm
Mallinckrodt
opioids
Purdue Pharma
bankruptcy
legal
Mallinckrodt obtains FDA approval for StrataGraft to treat thermal burns
Pharmaceutical Business Review
Wed, 06/16/21 - 11:42 am
Mallinckrodt
FDA
StrataGraft
thermal burns
burns
regenerative medicine
‘There’s so much uncertainty’: As Mallinckrodt sells rare disease drug, parents worry about access
Stat
Thu, 05/20/21 - 11:06 pm
Mallinckrodt
Niemann-Pick disease
Mallinckrodt faces regulatory delay as COVID-19 restrictions continue to upend FDA's inspection schedule
Fierce Pharma
Sat, 02/13/21 - 10:58 pm
Mallinckrodt
COVID-19
FDA
StrataGraft
drug manufacturing
FDA Action Alert: Adamas, Mallinckrodt and Merck
BioSpace
Tue, 02/2/21 - 11:02 am
FDA
Adamas Pharmaceuticals
Mallinckrodt
Merck
Gocovri
StrataGraft
Keytruda
triple negative breast cancer
Mark Your Calendar For February PDUFA Dates
Yahoo/Benzinga
Sun, 01/31/21 - 10:18 pm
FDA
Adamas Pharmaceuticals
Gocovri
Mallinckrodt
StrataGraft
Regeneron
evinacumab
Sanofi
Sarepta
TG Therapeutics
Go or no go? Oncology decisions ahead for the FDA
EP Vantage
Wed, 01/27/21 - 11:55 am
FDA
cancer
oncology
Bristol-Myers Squibb
TG Therapeutics
Mallinckrodt
Sanofi
Regeneron
Sarepta Therapeutics
GSK
Oncopeptide
Drowning in litigation, Mallinckrodt becomes third opioid producer to file for bankruptcy
Endpoints
Mon, 10/12/20 - 10:46 am
Mallinckrodt
opioid crisis
opioids
bankruptcy
Novartis, Amgen and Mallinckrodt used aggressive price hikes to meet sales goals, congressional probe finds
Fierce Pharma
Thu, 10/1/20 - 11:29 am
congress
drug pricing
Novartis
Amgen
Mallinckrodt
Pages
1
2
3
4
5
6
7
next ›
last »